With the prolongation of storage time, the solubility of preserved egg white gel at 3 storage temperatures showed a trend of first decreasing and then increasing in S1 ( P < 0.05), the solubility in S4 increased first and then decreased ( P < 0.05), and there was no obvious change trend in S2 and S3 parts.
The following factors showed a trend toward being risk factors on multivariate analysis: CNS disease (OR = 2.24, 95% CI: 1.00-5.01, p = 0.050), renal dysfunction (OR = 2.01, 95% CI: 0.98-4.13, p = 0.058), male gender (OR = 1.75, 95% CI: 0.93-3.29, p = 0.082), higher age (OR = 1.70, 95% CI: 0.95-3.03, p = 0.075), combined resection (OR = 2.85, 95% CI: 0.88-9.27, p = 0.081), and extended operating time (OR = 1.61, 95% CI: 0.95-2.73, p = 0.079).
FPS cells treated with 100 n m PGF 2α or hypoxia showed a trend toward increased VEGF mRNA expression; this increase reached significance when both factors were present simultaneously ( P < 0.05) ( Fig. 2 A).
100 mg/kg PPMO-treated mice), while lower (30 mg/kg) and intermittent doses (50 mg/kg) showed a trend toward improved strength ( p < 0.05, WT and untreated mdx vs. lower and intermittent dose PPMO-treated mdx mice) ( Figure 6 A).
In the range of a liquid–solid ratio of 20~60 mL/g, with the increase in the liquid–solid ratio, the scavenging activity AVE to oxidizing free radicals showed a trend of first increasing and then gradually decreasing ( p < 0.05).
All patients showed a trend to lower blood pressure, SVR, and inotropy (P<0.05), but HR, SV, and CO returned to baseline values after 6 weeks treatment (P>0.05).
Loading KFs with higher amounts of DEX, either by the addition of solubilizing agents or by suspension of the API, showed a trend towards a slightly reduced US level ( P < 0.05).
In addition, the VF-MD showed a trend toward a difference between the EZ-preserved group (14.30 ± 7.68 dB) and the EZ-atrophy group (19.04 ± 4.93 dB; P = 0.05).
Conversely, the relative contents of sweet amino acids showed a trend of decreasing and then increasing ( p < 0.05).
Finally, the Proteobacteria showed a trend of increasing with age: the relative abundance of Proteobacteria in the 100-day-old group was significantly higher than that in the 80-day-old group (P<0.05).
The MDS-UPDRS motor (III) ( Table S1 ) mean score showed a trend of improvement in the Enhanced Mel group [−6.43 (−12.85 to −1.01), p = 0.05].
After the multivariate analysis, with the inclusion of the following variables: on-pump surgery, current smoke and age, performing on-pump CABG showed a trend for association with the short-term combined end point, p = 0.05.
I h showed a trend dependent on different treatments and exposure times ( p < 0.05) for both organs analyzed.
Accordingly, the analysis of the glucagon/insulin ratio in all groups tested showed a trend to increase with respect to the corresponding ratio observed at 0 min; this increase was statistically significant after 60 min ( p < 0.05) of 100 mg/Kg D-Pinitol ( Figure 2 A) dose, and after 120 min ( p < 0.05) of 500 mg/Kg dose of D-Pinitol ( Figure 2 B).
Notably, along the increasing PAH concentrations in soil, the average niche width (8.83–11.05) of the community showed a trend of gradual increase ( Figure 4A ; ANOVA, p < 0.05).
Comparison of the number of intracellular ATP molecules in 2-, 6-, 12-, and 18-month-old neurons showed a trend of increase with age, which was signed between the 2- and 12-month neurons ( Figure 5 A; p < 0.05).
With respect to the lipid profile, although total cholesterol and high-density lipoprotein (HDL) levels showed a trend toward variation between the groups, these differences did not reach statistical significance ( P > 0.05) [ Table 3 ].
However, when either extract was administered once daily for three consecutive days, spleen IFN-γ levels increased significantly by EJHE (p < 0.02) and showed a trend toward an increase by EJHE-WR (p >0.05) (Figure 3A ).
Patients with obesity had a significantly lower risk of all‐cause mortality compared to normal‐weight patients (HR 0.78; 95% CI 0.66–0.92; P = 0.003) and patients with overweight showed a trend compared to normal‐weight patients (HR 0.86; 95% CI 0.74–1.00; P = 0.05).
Scores in hepatology, as well as biliary and pancreatic study, showed a trend toward improvement ( p >0.05).
In this initial trial, young adult neurabin KO mice showed a trend toward reduced immobility compared with matched WT mice ( p = 0.05, Fig 3A ).
In lymph nodes, only the suspension group showed a trend toward elevated CD4 + Foxp3 + T cells relative to the model group ( p < 0.05). 4.
Additionally, a few more channels that showed a trend-level difference (uncorrected p<0.05 but not remaining significant after FDR correction) were located approximately in the bilateral frontopolar ([FP]), dorsolateral ([DL]) and ventrolateral ([VL]) regions (uncorrected p<0.01; [FP] ch 36 (d = 0.83; 95%IC 0.19, 1.43), ch47 (d = 0.93; 95%IC 0.26,1.56
This is supported by a sub-analysis in KMT2A -rearranged patients, where TRM was similar in both groups, and OS showed a trend towards improvement (63% vs 53%, p=0.05). 11 Despite the lack of benefit in terms of OS in the total cohort, the results of this trial ultimately led to FDA approval for de novo AML patients aged ≥1 month.
Given that sample diversities were significantly different between the D0 and D+ samples ( p < 0.05), diversities for all indices were different by blood culture result (sterile or below/above threshold; p < 0.05) and by positivity of a blood culture sample ( p < 0.05, except for Unifrac parameters, which only showed a trend) ( Figure 2 ). 2.3.